Bioflavonoids and zinc glycinate and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Bioflavonoids and zinc glycinate and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bioflavonoids / zinc glycinate
Brand name: Limbrel250, Limbrel500
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bioflavonoids and zinc glycinate-Insulin glargine, recombinant Subcutaneous
- Bioflavonoids and zinc glycinate-Insulin glulisine
- Bioflavonoids and zinc glycinate-Insulin Glulisine (Cartridges and Pens)
- Bioflavonoids and zinc glycinate-Insulin Glulisine (Vials)
- Bioflavonoids and zinc glycinate-Insulin glulisine Subcutaneous
- Bioflavonoids and zinc glycinate-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Bionatuss
- Insulin glargine and lixisenatide Subcutaneous-Biospec DMX
- Insulin glargine and lixisenatide Subcutaneous-Biotalan Clear
- Insulin glargine and lixisenatide Subcutaneous-BioThrax
- Insulin glargine and lixisenatide Subcutaneous-Biothrax Vaccine
- Insulin glargine and lixisenatide Subcutaneous-Biotussin DAC